Stock listing
Cabaletta Bio, Inc.
Selected listing: CABA · NASDAQ · USD · US
Cabaletta Bio, Inc. (NASDAQ:CABA), Health Technology. Latest release Oct 5, 2026: Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
- Ticker
- NASDAQ:CABA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Cabaletta Bio, Inc.
Cabaletta Bio, Inc. is a public biotechnology company based in the United States, focused on developing innovative cell therapies for autoimmune diseases. Cabaletta Bio is committed to advancing its research and development efforts in the field of immunotherapy.
Latest news from Cabaletta Bio, Inc.
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 5, 2026
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 4, 2026
Cabaletta Bio to Participate in Upcoming Investor Conferences
September 1, 2026
Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026
Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
June 3, 2026
Events
Replays
Cabaletta Bio, Inc. (CABA) Q3 2024 Earnings Call
Wed, Nov 20, 2024 · 08:00 AM ET
Watch
Research Cabaletta Bio, Inc.
Alternate listings
CABA:BOATS
US · USD
Alternate listing for Cabaletta Bio, Inc.; the primary context on this page is CABA:NASDAQ.
CABA:BMV
MX · MXN
Alternate listing for Cabaletta Bio, Inc.; the primary context on this page is CABA:NASDAQ.
CABA:BIVA
MX · MXN
Alternate listing for Cabaletta Bio, Inc.; the primary context on this page is CABA:NASDAQ.